Exodus Point Capital Management, LP Caribou Biosciences, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 158,612 shares of CRBU stock, worth $253,779. This represents 0.01% of its overall portfolio holdings.
Number of Shares
158,612Holding current value
$253,779% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding CRBU
# of Institutions
157Shares Held
67.4MCall Options Held
111KPut Options Held
105K-
Black Rock Inc. New York, NY7.01MShares$11.2 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA6.48MShares$10.4 Million1.64% of portfolio
-
State Street Corp Boston, MA6.35MShares$10.2 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX5.79MShares$9.26 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.11MShares$6.58 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $97.3M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...